COAG Hemab Therapeutics Holdings, Inc.: institutional ownership and insider trading

59 funds reported holding $1.33B of Hemab Therapeutics Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.33B, with 56 new positions and 0 funds selling out; over the last 12 months insiders bought $55.5M and sold $0 on the open market.

COAG revenue and earnings

Famous investors holding COAG

Largest institutional holders of COAG

  1. RA CAPITAL MANAGEMENT, L.P. — $287M
  2. Novo Holdings A/S — $154M
  3. FMR LLC — $136M
  4. Capital International Investors — $132M
  5. Deep Track Capital, LP — $132M
  6. Siren, L.L.C. — $76.6M
  7. Avoro Capital Advisors LLC — $70.7M
  8. Bain Capital Life Sciences Investors, LLC — $60.6M
  9. JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $42.3M
  10. VANGUARD CAPITAL MANAGEMENT LLC — $28.7M

Recent COAG insider trades

5%+ owners

Who owns the most COAG stock?

The largest institutional holders of Hemab Therapeutics Holdings, Inc. in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($287M), Novo Holdings A/S ($154M), FMR LLC ($136M).

Are insiders buying or selling COAG?

Over the last 12 months insiders bought $55.5M and sold $0 of Hemab Therapeutics Holdings, Inc. stock on the open market (SEC Form 4).

Which famous investors own COAG?

George Soros, Ken Griffin, Two Sigma.

Which ETFs hold COAG?

4 ETFs and mutual funds hold it among their top 100 positions, including JGLYX, FBIOX, FBTAX, DMCRX.

All COAG 13F holders · All COAG insider trades